Internal Grant Agency FM MU

About InGA

The aim of the Internal Grant Agency of Faculty of Medicine of Masaryk University (InGA) is to enhance the quality and prestige of research at FM MU, to increase the success of FM MU in obtaining national and international prestigious grants, to increase the potential for practical application of research results, and to support internationalisation and sustainability of human resources in FM MU research. The support is intended for FM MU staff involved in research. Emphasis is placed on the research excellence of the applicants and the quality of the submitted project proposals and projects.

6

grant schemes

49

supported projects

24 mil. CZK

annual budget

Types of grants

InGA competitions are announced in the following categories:

 

Start-up grants are designed to support pilot projects for new research programmes. The aim is to obtain pilot data, to introduce and validate a new methodology, and to provide the basis for the development of a full-fledged project funded by an external grant agency. A necessary outcome of the project is the submission of a project application to an external grant agency with FM MU as the main beneficiary/applicant.

Only the head of an already established research group of an FM MU department, or his/her immediate superior, can apply for "Sustainability Support", while the research group must be at least partially funded from external grant schemes. The aim is to be able to support the funding of personnel and other costs of the research group on the basis of an individual application (usually to bridge the period between individual grant schemes), for a maximum of 12 months. The outcome is the submission of a project application for funding to an external grant agency.

The main goal of the "FM Award" grant is to bring new outstanding and successful scientists to the FM MU  and to offer them such conditions that they will be motivated to stay working for the FM  MU  and to produce outstanding scientific results in the long term. This form of support is therefore primarily intended for senior level foreign scientists (i.e. at least after the postdoc fellowship), and alternatively also for senior level internal researchers with significant foreign experience.

The competition serves to attract experienced productive junior researchers with significant international experience and their integrate them into already established research groups at FM MU. The aim is also to strengthen the international character of the FM MU academic environment.

InGA Board

Members of InGA Board

prof. MUDr. Martin Smrčka, Ph.D., MBA

Deputy for Science and Research at University Hospital Brno

prof. MUDr. Jan Krejčí, Ph.D.

Deputy for Science and Research at St. Anne's University Hospital

doc. MUDr. Tomáš Kazda, Ph.D.

Director for Science and Research Masaryk Memorial Cancer Institute

Calls

Calls for projects implemented in 2025

Start-up grants

FM Accelerate

Junior Research Group

This call will not be launched for 2025.

Postdoc

Calls for projects implemented in 2023

Start-up grants

FM Accelerate

Junior Research Group

Call

29. 11. 2022

For the first time ever, the internal grant agency of FM MU announces the program "Junior Research Group at FM MU", which will fund 1 new group of junior researchers at FM MU for 3 years. Such a scientist has completed his/her Ph.D. max. 7 years ago, has been working outside the Czech Republic for at least 2 years in the last 3 years or has completed his/her Ph.D. studies abroad, has published at least 2 articles above the median WoS category in the last 3 years and is the main author of at least one article (first author, corresponding author). Do you know anyone? Do you know anyone? Never mind. We will post ads on international portals on your behalf and arrange interviews to select the best candidate. If you are interested, get in touch by December 2, 2022 at projekty@med.muni.cz.

Postdoc

Call

29. 11. 2022

The internal grant agency of FM MU offers funding for 2 postdoctoral positions for 2 years. Do you know of anyone who completed their Ph.D. max. 7 years ago, has worked outside the Czech Republic for at least 2 years in the last 3 years, or completed their Ph.D. studies abroad, and has published at least 3 articles in the last 3 years, at least 2 of which are in Q1? Do you know? Never mind. We will publish advertisements on international portals on your behalf and organize interviews, during which the two best candidates will be selected. If you are interested, get in touch by December 2, 2022 at projekty@med.muni.cz.

Supported projects
Projects supported in 2025

Start-up grants

Projects supported in 2024

Start-up grants

Postdoc

InGA Postdoc in Primary Cilia

Group leader: Mgr. Lukáš Čajánek, Ph.D.

Postdoc: Dr. Annette Jacobsen, a successful candidate from the University of Melbourne, will focus on the mechanisms and functions of primary cilia.

InGa Postdoc in Cardiomyocytes

Group leader: Mgr. Vladimír Rotrekl, Ph.D.

Postdoc: Dr. Michelle Geryk from Nantes University will work on the study of the cardiomyocytes differentiated from patients harbouring cardiac mutations resulting in arrhythmia and/or cardiomyopathy.

Junior research group

Zdenek Andrysik Research Group: Molecular Mechanisms of Cancer

Junior group leader: Zdenek Andrysik, Ph.D.

The scientific program of Dr. Andrysik´s research group is designed to accomplish the mission of the laboratory: to save lives through research of transcription factors (TFs) involved in carcinogenesis and identification of the treatment opportunities represented by targeting TFs. Cancer occurs from genetic and epigenetic alterations resulting in deregulated transcriptional programs, which are associated with virtually all hallmarks of cancer. Aberrant activity of TFs constitutes cancer dependency and earmarks TFs as targets in the treatment of particular malignancies, such as cancers dependent on nuclear hormone receptors. Acting both as oncogenes and tumor suppressors, TFs are no longer considered as “undruggable” as ever-increasing portfolio of compounds is available for research and treatment applications while novel technologies increase drug specificity. Taken together, TFs represent a prime target for designing innovative treatment strategies and facilitating personalized medicine.

Projects supported in 2023

Start-up grants

Analysis of bacterial agents of acute otitis media using modern techniques

Principal investigator: doc. MUDr. Milan Urík, Ph.D.

The aim of this project is to collect data and gain new insight into the pathogenesis of acute otitis media and to significantly modify preventive, diagnostic and therapeutic recommendations.

 

 

Protective potential of sigma ligands and antihypertensives in doxorubicin cardiotoxicity: a comprehensive experimental approach

Principal investigator: prof. MUDr. Marie Nováková, Ph.D.

The aim of the project is to establish and validate a model of doxorubicin cardiotoxicity and to study the effect of an antihypertensive agent and a sigma 1 ligand with a predicted cardioprotective potential.

 

WNT signalling in mammary fibroblasts

Principal investigator: Mgr. Zuzana Sumbalová Koledová, Ph.D.

In this project, we aim to develop a toolkit to investigate WNT signaling in mammary fibroblasts in vivo and to obtain conclusive preliminary data on the role of WNT signaling in mammary fibroblasts in epithelial morphogenesis.

 

 

Monitoring the effects of alternative treatments on microbes by Raman spectroscopy

Principal investigator: Mgr. Mgr. Katarína Rebrošová

The project focuses on the effects of essential oils in sub-inhibitory concentrations and in plasma on growing bacteria using Raman spectroscopy - a powerful tool that can mirror chemical bonds present in various samples, including bacterial cells or colonies.

Role of Caveolin-1 in the biogenesis of phosphatidylserine-positive extracellular vesicles

Principal investigator: Mgr. Květa Pilařová, Ph.D.

This project focuses on novel functions of Caveolin-1 (Cav-1) and their possible oncogenic properties.

 

 

Introduction of a clinically relevant avian chorioallantoic membrane model in cancer research with a focus on migration and metastatic potential of tumor cells and tumor angiogenesis

Principal investigator: Ing. Hana Holcová Polanská, Ph.D.

Assessment of response to treatment in the chick chorionic allantoic membrane (CAM) model may represent a useful screening tool for personalized medicine with the potential to improve patient treatment and outcomes.

Pentamethinium salts, new potential inhibitors of cancer cell migration

Principal investigator: Ing. Kateřina Petrláková

The main goal of this project is to find PMS with high migration and antiproliferative potential against cancer cells.

 

 

Proteomic composition of phosphatidylserine-positive extracellular vesicles released during cell death as a marker for personalized medicine.

Principal Investigator: RNDr. Jan Balvan, Ph.D.

Jan Jan Balvan, Ph.D. The aim of the project is to investigate the specific and sensitive detection of different types of cell death in vivo to monitor the response of cell population to therapy with specific molecules.

Possibilities of using specific nanofibers for application to visceral serosa

Principal investigator: doc. MUDr. Igor Penka, CSc.

The aim of the project is the possibility of application of nanomaterials on visceral peritoneum, investigation of adhesiveness of specific nanomaterials on this surface, its degradability and at the same time promotion of healing.

Retinal organoids as a tool for the study of embryonic diabetic retinopathy

Principal Investigator: Mgr. Tomáš Bárta, Ph.D.

 


In this project, we will use retinal organoids derived from induced pluripotent stem cells (hiPS) as a model to further investigate the effects of hyperglycemia on human retinal development.

 

Studying the early development of Alzheimer's disease pathology using brain organoids

Principal investigator: Mgr. Dáša Bohačiaková, Ph.D.

 


The aim of this project is to discover the mechanisms that lead to the development of Alzheimer's disease.

 

 

Possible influence of non-biomechanical factors on the development of adjacent segment disease in patients undergoing single-segment stabilization surgery for degenerative lumbar spine disease

Principal investigator: Mgr. Júlia Bohošová, Ph.D.

The aim of the project is to investigate microRNAs in perioperative tissue samples and blood plasma as potential factors involved in the development of ASD in patients operated for DDD or degenerative spondylolisthesis with single-segment stabilization, and subsequent possibilities of its prevention or slowing down.

Postdoc

InGA Postdoc in Stem Cell and Developmental Biology Research

Investigator: doc. Mgr. Jan Křivánek, Ph.D.

Dr. Maryam Azam, the successful candidate, will focus on fundamental aspects of developmental biology and its connection to regenerative medicine, helping the group to unravel the mechanisms involved in maintaining stem cell niche homeostasis, stem cell activation after injury, and the processes controlling cell differentiation at the molecular level.

InGA Postdoc in Metals in Implantology

Principal investigator: prof. RNDr. Monika Pávková Goldbergová, Ph.D.

Dr. Daniel Wojtas will be responsible for the analysis and interpretation of data from various assays, including genomics, methylomics, proteomics and toxicity data. The overarching goal is to elucidate the biological mechanisms controlling healing and immune processes to improve metal incorporation.

 

Junior research group

Alemeh Zamani Research Group: Choroid Plexus in Diseases

Junior group leader: Alemeh Zamani, Ph.D.

Dr. Zamani's junior research group will focus on dysfunctions of the choroid plexus associated with various neurological disorders, including neuroinflammation and neurodegeneration. They will strive to expand knowledge about its pathophysiological mechanisms, particularly in Alzheimer's disease and chemotherapy-induced neuropathy.

Projects supported in 2022

Start-up grants

Role of miRNAs in the spread of Glioblastoma multiforme through brain tissue in vitro

Principal investigator: Mgr. Dáša Bohačiaková, Ph.D.

The aim of this project is to use a newly developed model of Glioblastoma multiforme (GBM) cultured using human brain organoids and to identify the molecular mechanisms that are activated after GBM interaction with healthy brain tissue.

 

Establishment of embryoid/gastruloid technology for the study of primary cilium signalling

Principal investigator: Mgr. Michaela Bosáková, Ph.D.

The aim of the project is to establish a gastruloid/embryoid methodology for the study of receptor tyrosine kinase signalling in the primary cilia and to determine the relevance of this type of signalling for early embryonic development.

 

Modelling loss of ciliary function using human pluripotent cells

Principal Investigator: Mgr. Lukáš Čajánek, PhD.

The aim of the project is to study causality between defective cilia and key processes of embryonic development (proliferation, differentiation). A key attribute of the project is the use of human pluripotent stem cell lines to model these processes in a controlled tissue culture environment.

Continuous xenotransplantation model of acute myeloid leukemia

Principal Investigator: PharmDr. Martin Čulen, Ph.D.

The aim of the project is to extend the experimental capabilities for in vivo models of acute myeloid leukemia (AML) and to test the continuous passaging of primary samples from AML patients in the mouse. The established in vivo AML collection will enable reproducible and nearly unlimited in vivo treatment testing and expansion of primary cells for other purposes that would not be capaciously possible using only vitally frozen samples.

Liquid kidney biopsy: isolation and expansion of proximal tubular cells from urine as a crucial step for the study of pathophysiology and eventual diagnosis of diabetic kidney disease

Principal investigator: Mgr. Katarína Chalásová, Ph.D.

The project aims to introduce and optimize for routine use the method of isolation of proximal tubular cells (PTEC) from human urine as (A) a potential diagnostic method ("liquid kidney biopsy") and (B) to obtain pathophysiologically relevant experimental material for the study of diabetic kidney disease.

Methods for measurement of mechanical forces on cell and tissue scale in organoids

Principal investigator: Mgr. Zuzana Sumbalová Koledová, Ph.D.

This project develops protocols for quantifying mechanical force in organoid cultures, including micropipette aspiration and laser ablation.

 

 

 

Characterization of a newly identified stem cell niche in continuously growing teeth

Principal investigator: doc. Mgr. Jan Křivánek, Ph.D.

The aim of the project is to reveal a previously unknown function of an uncharacterized type of mesenchymal stem cells in a continuously growing tooth.

 

Optimization of longitudinal hair cortisol determination for clinical applications

Principal investigator: doc. Mgr. Ondřej Peš, Ph.D.

The aim of the project is longitudinal monitoring of hair cortisol using liquid chromatography-mass spectrometry for determination and comparison of hair cortisol levels in healthy volunteers as well as in indicated patient groups.

Effect of social isolation on myocardial remodeling - role of sigma 1 receptors

Principal Investigator: MUDr. Tibor Stračina, Ph.D.

The aim of the project is to establish and validate a new model of myocardial remodelling induced by aortic ligation in the rat and to determine the effect of social isolation of rats on sigma 1 receptor expression and progression of myocardial remodelling.

Evaluation of cartilage cell parameters isolated from arthritic patient tissue in the context of the influence of the most commonly used intra-articular chondroprotective agents

Hlavní řešitel: Mgr. Lucie Válková, Ph.D.

Cílem projektu je komplexní hodnocení zánětlivého postižení chrupavky z pohledu metabolických dějů, ovlivnění zánětlivé reakce chondrocytů a redoxních dějů v kontextu vlivu nejběžněji klinicky používaných chondroprotektiv.

From dysfunction of the blood-cerebrospinal fluid barrier to neuroinflammation and Alzheimer's disease

Principal Investigator: Mgr. Lucie Válková, Ph.D.

The aim of the project is a comprehensive evaluation of inflammatory cartilage damage in terms of metabolic processes, influence of inflammatory response of chondrocytes and redox processes in the context of the influence of the most commonly used clinical chondroprotective agents.

Postdoc

Regulation of cartilage by phosphodiesterases

Principal Investigator: Pavel Krejčí, Ph.D.

The aim of the project of Gustavo Rico, Ph.D. from the University of Malaga, is to determine the expression and role of PDEs in the regulation of disc growth and articular cartilage.

 

Success stories

Success stories

Contacts

Ing. Veronika Weissová

Project manager, Grant Office

phone: +420 549 49 8728
e‑mail:

Start-up, Postdoc, Junior research group

Ing. Daniela Podzemná

Technology transfer assistant, Office for Research and Quality

phone: +420 549 49 6513
e‑mail:
LF Accelerate

You are running an old browser version. We recommend updating your browser to its latest version.

More info